{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:30:43Z","timestamp":1777883443074,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Medicine Access"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The World Health Organization (WHO) Model List of Essential Medicines guides countries in selecting priority drugs to ensure equitable access to effective treatments. In regions such as Central America, with similar health and socioeconomic contexts, comparing national lists reveals patterns and opportunities for regional harmonization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>A cross-sectional comparative observational study was conducted using public secondary data from the official essential medicines lists of seven Central American countries: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama. These lists were compared against the 2017 WHO Model List. Therapeutic classification was based on the Anatomical, Therapeutic, and Chemical Classification (ATC) system (level 2). Macroeconomic variables, including health expenditure per capita and gross domestic product (GDP) per capita, were analyzed for their relationship with list composition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Panama had the most extensive NEML (570 drugs) and Nicaragua the shortest (271 drugs). Nicaragua showed the highest alignment with the WHO list, while Panama had the most exclusive drugs. A significant positive correlation was found between health expenditure per capita and NEML size (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2009=\u20090.77;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.042), but not with alignment to the WHO list. The most represented therapeutic groups were antibacterials (31.2%) and antineoplastics (24.4%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Although Central American countries share regional similarities, their selection of essential medicines varies considerably. These differences reflect diverse public health priorities, institutional capacities, and economic conditions. The findings support the need for evidence-based, context-sensitive approaches and underscore the potential for regional cooperation in essential medicines policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/27550834251391077","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T04:28:50Z","timestamp":1764649730000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Essential medicines in Central America: Analysis of national lists, macroeconomic factors, and alignment with health priorities"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5459-7370","authenticated-orcid":false,"given":"Ernesto","family":"Mart\u00ednez-Vargas","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital Cl\u00ednica B\u00edblica, San Jos\u00e9, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8547-7745","authenticated-orcid":false,"given":"Sebastian","family":"Arguedas-Chac\u00f3n","sequence":"additional","affiliation":[{"name":"Investigation Department, Hospital Cl\u00ednica B\u00edblica, San Jos\u00e9, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Universidad de Ciencias M\u00e9dicas, San Jos\u00e9, Costa Rica"},{"name":"Intern Student, Hospital Clinica B\u00edblica, San Jos\u00e9, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0543-2262","authenticated-orcid":false,"given":"Jeaustin","family":"Mora-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Cl\u00ednica B\u00edblica, San Jos\u00e9, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7272-1642","authenticated-orcid":false,"given":"Kevin","family":"Cruz-Mora","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universidad de Costa Rica, San Jos\u00e9, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-0079","authenticated-orcid":false,"given":"Esteban","family":"Zavaleta-Monestel","sequence":"additional","affiliation":[{"name":"Investigation Department, Hospital Cl\u00ednica B\u00edblica, San Jos\u00e9, Costa Rica"},{"name":"School of Pharmacy, Universidad de Ciencias M\u00e9dicas, San Jos\u00e9, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.24.292359"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00176-1"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003944"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01549-6"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1517020"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.222448"},{"key":"e_1_3_3_8_2","unstructured":"EMLs around the world https:\/\/global.essentialmeds.org\/dashboard\/countries (accessed 21 May 2025)."},{"key":"e_1_3_3_9_2","unstructured":"National drug list. Ministry of Health of the Republic of Panama https:\/\/www.minsa.gob.pa\/informacion-salud\/lista-nacional-de-medicamento (accessed 21 May 2025)."},{"key":"e_1_3_3_10_2","unstructured":"List of medicines. Guatemalan Institute of Social Security https:\/\/www.igssgt.org\/listado-de-medicamentos\/ (accessed 21 May 2025)."},{"key":"e_1_3_3_11_2","unstructured":"Pan American Health Organization (PAHO)\/OPS. Health in the Americas. Country profile\u2014Costa Rica 2024 https:\/\/hia.paho.org\/es\/perfiles-de-pais\/costa-rica (accessed 22 May 2025)."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001883"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000101475.45195.b1"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czad118"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00796-4"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-23-1461"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2024.02.079"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102604"},{"key":"e_1_3_3_19_2","first-page":"100872","article-title":"A surveillance study of cancer incidence and mortality among young adults in Costa Rica","volume":"38","author":"Slimovitch R","year":"2024","unstructured":"Slimovitch R, Shing JZ, Fantin R, et al A surveillance study of cancer incidence and mortality among young adults in Costa Rica. Lancet Reg Health Am 2024; 38: 100872.","journal-title":"Lancet Reg Health Am"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100294"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16328-w"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Alfaro T Martinez-Folgar K Stern D et al Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study https:\/\/pubmed.ncbi.nlm.nih.gov\/39890227\/ (accessed 22 May 2025).","DOI":"10.1016\/S2214-109X(24)00446-7"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183348"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.11.078"},{"key":"e_1_3_3_25_2","article-title":"Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis","volume":"366","author":"Li DG","year":"2019","unstructured":"Li DG, Najafzadeh M, Kesselheim AS, et al Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis. BMJ 2019; 366: L4257.","journal-title":"BMJ"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12783"}],"container-title":["The Journal of Medicine Access"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/27550834251391077","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/27550834251391077","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/27550834251391077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:46:02Z","timestamp":1777599962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/27550834251391077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"alternative-id":["10.1177\/27550834251391077"],"URL":"https:\/\/doi.org\/10.1177\/27550834251391077","relation":{},"ISSN":["2755-0834","2755-0834"],"issn-type":[{"value":"2755-0834","type":"print"},{"value":"2755-0834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"27550834251391077"}}